Literature DB >> 8494371

Antimicrobial susceptibility of Acinetobacter species.

H Seifert1, R Baginski, A Schulze, G Pulverer.   

Abstract

The in vitro activities of 16 antimicrobial agents against 180 Acinetobacter strains isolated from blood cultures (n = 162), central venous catheters (n = 11), and cerebrospinal fluids (n = 7) were studied. MICs were determined by a microtiter broth dilution method. Considerable differences in antimicrobial drug susceptibility against strains belonging to different species could be demonstrated. Acinetobacter baumannii isolates (n = 108) were generally more resistant than isolates identified as species other than A. baumannii. Multidrug resistance was common among A. baumannii isolates. Of the antimicrobial agents tested, imipenem was highly active against all A. baumannii isolates, and the other agents tested were only moderately active or inactive. Good activity against Acinetobacter species strain 3 was demonstrated for imipenem, amikacin, and ciprofloxacin. Most of the strains belonging to other species were susceptible to imipenem, ciprofloxacin, expanded-spectrum cephalosporins, amoxicillin-clavulanate, and the aminoglycosides but were resistant to ampicillin and older cephalosporins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8494371      PMCID: PMC187751          DOI: 10.1128/AAC.37.4.750

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  beta-Lactamase and beta-lactam antibiotics resistance in acinetobacter anitratum (syn: A. calcoaceticus).

Authors:  T Morohoshi; T Saito
Journal:  J Antibiot (Tokyo)       Date:  1977-11       Impact factor: 2.649

2.  Acinetobacter calcoaceticus: a nosocomial pathogen with an unusual seasonal pattern.

Authors:  H F Retailliau; A W Hightower; R E Dixon; J R Allen
Journal:  J Infect Dis       Date:  1979-03       Impact factor: 5.226

3.  Isolation of Acinetobacter from soil and water.

Authors:  P Baumann
Journal:  J Bacteriol       Date:  1968-07       Impact factor: 3.490

Review 4.  Epidemiology of nosocomial infections due to Acinetobacter calcoaceticus.

Authors:  E Bergogne-Bérézin; M L Joly-Guillou; J F Vieu
Journal:  J Hosp Infect       Date:  1987-09       Impact factor: 3.926

5.  An underestimated nosocomial pathogen, Acinetobacter calcoaceticus.

Authors:  E Bergogne-Berezin; M L Joly-Guillou
Journal:  J Antimicrob Chemother       Date:  1985-11       Impact factor: 5.790

6.  [Comparative activity in vitro of ceftizoxime, ceftazidime and imipenem against Acinetobacter calcoaceticus].

Authors:  M L Joly-Guillou; E Bergogne-Bérézin
Journal:  Pathol Biol (Paris)       Date:  1986-06

7.  Comparative activity of imipenem, ceftazidime and cefotaxime against Acinetobacter calcoaceticus.

Authors:  E Bergogne-Berezin; M L Joly-Guillou
Journal:  J Antimicrob Chemother       Date:  1986-12       Impact factor: 5.790

8.  In vitro susceptibility of Acinetobacter species to various antimicrobial agents.

Authors:  K V Rolston; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

9.  Infections with Acinetobacter calcoaceticus (Herellea vaginicola): clinical and laboratory studies.

Authors:  R H Glew; R C Moellering; L J Kunz
Journal:  Medicine (Baltimore)       Date:  1977-03       Impact factor: 1.889

10.  The skin as the source of Acinetobacter and Moraxella species occurring in blood cultures.

Authors:  M S Al-Khoja; J H Darrell
Journal:  J Clin Pathol       Date:  1979-05       Impact factor: 3.411

View more
  38 in total

1.  Emergence of carbapenem-hydrolyzing enzymes in Acinetobacter baumannii clinical isolates.

Authors:  G J Da Silva; G J Leitão; L Peixe
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

2.  Detection of carbapenemase-producing Acinetobacter baumannii in a hospital.

Authors:  A Takahashi; S Yomoda; I Kobayashi; T Okubo; M Tsunoda; S Iyobe
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 3.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

4.  Validation of use of whole-cell repetitive extragenic palindromic sequence-based PCR (REP-PCR) for typing strains belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii complex and application of the method to the investigation of a hospital outbreak.

Authors:  A M Snelling; P Gerner-Smidt; P M Hawkey; J Heritage; P Parnell; C Porter; A R Bodenham; T Inglis
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

5.  Specificity of rabbit antisera against lipopolysaccharide of Acinetobacter.

Authors:  R Pantophlet; L Brade; L Dijkshoorn; H Brade
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

6.  Comparison of ribotyping and pulsed-field gel electrophoresis for molecular typing of Acinetobacter isolates.

Authors:  H Seifert; P Gerner-Smidt
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

7.  Oligonucleotide array-based identification of species in the Acinetobacter calcoaceticus-A. baumannii complex in isolates from blood cultures and antimicrobial susceptibility testing of the isolates.

Authors:  Wen-Chien Ko; Nan-Yao Lee; Siou Cing Su; Lenie Dijkshoorn; Mario Vaneechoutte; Li-Rong Wang; Jin-Jou Yan; Tsung Chain Chang
Journal:  J Clin Microbiol       Date:  2008-04-02       Impact factor: 5.948

8.  Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem.

Authors:  S K Spangler; M A Visalli; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

Review 9.  Bacteremia due to Acinetobacter species other than Acinetobacter baumannii.

Authors:  H Seifert; A Strate; A Schulze; G Pulverer
Journal:  Infection       Date:  1994 Nov-Dec       Impact factor: 3.553

10.  Emergence of resistant isolates of Acinetobacter calcoaceticus- A. baumannii complex in a Spanish hospital over a five-year period.

Authors:  M I García-Arata; T Alarcón; M López-Brea
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-06       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.